Group One Trading
GSK icon

Group One Trading’s GSK GSK Stock Holding History

Group One Trading’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,563
Closed -$1.51M – 8679
2025
Q2 		$1.48M Buy
+38,563
New +$1.47M ﹤0.01% 2412
2025
Q1 		– Sell
-21,467
Closed -$786K – 7886
2024
Q4 		$726K Buy
+21,467
New +$773K ﹤0.01% 2871
2023
Q2 		– Sell
-14,524
Closed -$521K – 7864
2023
Q1 		$517K Sell
14,524
-153,442
-91% -$5.37M ﹤0.01% 2753
2022
Q4 		$5.9M Buy
167,966
+54,201
+48% +$1.81M 0.01% 1042
2022
Q3 		$3.35M Buy
113,765
+54,532
+92% +$2.07M 0.01% 1485
2022
Q2 		$3.22M Sell
59,233
-84,290
-59% -$4.65M 0.01% 1625
2022
Q1 		$7.82M Buy
143,523
+22,000
+18% +$1.19M 0.01% 1173
2021
Q4 		$6.7M Buy
121,523
+11,727
+11% +$610K 0.01% 1434
2021
Q3 		$5.24M Sell
109,796
-93,301
-46% -$4.69M 0.01% 1637
2021
Q2 		$10.1M Buy
203,097
+93,143
+85% +$4.48M 0.01% 1069
2021
Q1 		$4.91M Buy
109,954
+85,361
+347% +$3.87M 0.01% 1531
2020
Q4 		$1.13M Buy
24,593
+10,707
+77% +$492K ﹤0.01% 2532
2020
Q3 		$653K Buy
+13,886
New +$696K ﹤0.01% 2609
2017
Q2 		– Sell
-46
Closed -$2.45K – 4870
2017
Q1 		$2K Sell
46
-26,097
-100% -$1.32M ﹤0.01% 4448
2016
Q4 		$1.26M Buy
+26,143
New +$1.29M 0.01% 1183
2016
Q3 		– Sell
-10,458
Closed -$573K – 4669
2016
Q2 		$567K Sell
10,458
-7,313
-41% -$385K 0.01% 1645
2016
Q1 		$901K Buy
17,771
+13,030
+275% +$649K 0.01% 1251
2015
Q4 		$239K Sell
4,741
-32,025
-87% -$1.63M ﹤0.01% 2371
2015
Q3 		$1.77M Buy
36,766
+10,767
+41% +$560K 0.02% 866
2015
Q2 		$1.35M Buy
25,999
+20,249
+352% +$1.14M 0.02% 991
2015
Q1 		$332K Buy
5,750
+460
+9% +$26.4K 0.01% 1949
2014
Q4 		$283K Buy
5,290
+3,440
+186% +$192K ﹤0.01% 2015
2014
Q3 		$106K Buy
1,850
+1,770
+2,213% +$109K ﹤0.01% 2925
2014
Q2 		$5K Buy
+80
New +$5.42K ﹤0.01% 4752

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading's GSK Position: Q3 2025 in Review

Group One Trading sold out of GSK (GSK) in Q3 2025, closing a stake of 38,563 shares — an estimated $1.51M sold.

Group One Trading first reported a position in GSK in Q2 2014 and held it in 24 quarters. The position peaked at $10.1M in Q2 2021. 896 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Group One Trading reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 38,563 GSK shares in Q3 2025, an estimated $1.51M.
  • Group One Trading first reported a position in GSK in Q2 2014 and held it in 24 quarters.
  • Group One Trading's GSK position peaked at $10.1M in Q2 2021.
  • 896 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.